Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Prognostic value of parapharyngeal extension in nasopharyngeal carcinoma treated with intensity modulated radiotherapy.

Tang LL, Sun Y, Mao YP, Chen Y, Li WF, Chen L, Liu LZ, Lin AH, Li L, Ma J.

Radiother Oncol. 2014 Mar;110(3):404-8. doi: 10.1016/j.radonc.2013.10.007. Epub 2013 Oct 30.

PMID:
24183063
[PubMed - in process]
2.

Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.

Sun Y, Tang LL, Chen L, Li WF, Mao YP, Liu LZ, Lin AH, Li L, Ma J.

BMC Cancer. 2012 Feb 15;12:68. doi: 10.1186/1471-2407-12-68.

PMID:
22336097
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Prognostic value of prevertebral space involvement in nasopharyngeal carcinoma based on intensity-modulated radiotherapy.

Zhou GQ, Mao YP, Chen L, Li WF, Liu LZ, Sun Y, Chen Y, Tian L, Lin AH, Li L, Ma J.

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1090-7. doi: 10.1016/j.ijrobp.2010.11.063. Epub 2011 Aug 22.

PMID:
21864993
[PubMed - indexed for MEDLINE]
4.

MRI-detected skull-base invasion : Prognostic value and therapeutic implication in intensity-modulated radiotherapy treatment for nasopharyngeal carcinoma.

Cheng YK, Liu LZ, Jiang N, Yue D, Tang LL, Zhang F, Lin L, Liu X, Chen L, Ma J.

Strahlenther Onkol. 2014 Apr 25. [Epub ahead of print]

PMID:
24763663
[PubMed - as supplied by publisher]
5.

Prognostic value of prepontine cistern invasion in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy.

Hung TM, Chen CC, Lin CY, Ng SH, Kang CJ, Huang SF, Liao CT, Fan KH, Wang HM, Chang JT.

Oral Oncol. 2014 Mar;50(3):228-33. doi: 10.1016/j.oraloncology.2013.12.005. Epub 2014 Jan 6.

PMID:
24394562
[PubMed - in process]
6.

Intensity-modulated radiotherapy for stage IVA/IVB nasopharyngeal carcinoma : Clinical outcomes and patterns of failure in an endemic area in China.

Zeng L, Tian YM, Sun XM, Huang Y, Chen CY, Han F, Liu S, Lan M, Guan Y, Deng XW, Lu TX.

Strahlenther Onkol. 2014 May 17. [Epub ahead of print]

PMID:
24838409
[PubMed - as supplied by publisher]
7.

Prognostic value of tumor volume for patients with nasopharyngeal carcinoma treated with concurrent chemotherapy and intensity-modulated radiotherapy.

Wu Z, Su Y, Zeng RF, Gu MF, Huang SM.

J Cancer Res Clin Oncol. 2014 Jan;140(1):69-76. doi: 10.1007/s00432-013-1542-x. Epub 2013 Oct 31.

PMID:
24173695
[PubMed - indexed for MEDLINE]
8.

Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma?

Guo R, Sun Y, Yu XL, Yin WJ, Li WF, Chen YY, Mao YP, Liu LZ, Li L, Lin AH, Ma J.

Radiother Oncol. 2012 Sep;104(3):294-9. doi: 10.1016/j.radonc.2012.09.001. Epub 2012 Sep 19.

PMID:
22998947
[PubMed - indexed for MEDLINE]
9.

Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma detected by magnetic resonance imaging : prognostic value and staging categories.

Tang L, Li L, Mao Y, Liu L, Liang S, Chen Y, Sun Y, Liao X, Tian L, Lin A, Liu M, Ma J.

Cancer. 2008 Jul 15;113(2):347-54. doi: 10.1002/cncr.23555.

PMID:
18459174
[PubMed - indexed for MEDLINE]
Free Article
10.

Involvement of both cervical lymph nodes and retropharyngeal lymph nodes has prognostic value for N1 patients with nasopharyngeal carcinoma.

Shi Q, Shen C, Kong L, Wang X, Ding J, Gao Y, Xu T, Hu C.

Radiat Oncol. 2014 Jan 6;9:7. doi: 10.1186/1748-717X-9-7.

PMID:
24393418
[PubMed - in process]
Free PMC Article
11.

Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.

Ozyar E, Gurkaynak M, Yildiz F, Atahan IL.

Radiother Oncol. 2004 Jul;72(1):71-7.

PMID:
15236877
[PubMed - indexed for MEDLINE]
12.

Outcomes and prognostic factors of conformal radiotherapy versus intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Kuang WL, Zhou Q, Shen LF.

Clin Transl Oncol. 2012 Oct;14(10):783-90. doi: 10.1007/s12094-012-0864-5. Epub 2012 Jul 24.

PMID:
22855156
[PubMed - indexed for MEDLINE]
13.

Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis.

Zhou GQ, Tang LL, Mao YP, Chen L, Li WF, Sun Y, Liu LZ, Li L, Lin AH, Ma J.

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e359-65. doi: 10.1016/j.ijrobp.2011.06.1967. Epub 2011 Oct 12. Erratum in: Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):213.

PMID:
22000748
[PubMed - indexed for MEDLINE]
14.

Tumor volume is an independent prognostic indicator of local control in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.

Feng M, Wang W, Fan Z, Fu B, Li J, Zhang S, Lang J.

Radiat Oncol. 2013 Sep 5;8(1):208. doi: 10.1186/1748-717X-8-208.

PMID:
24007375
[PubMed - in process]
Free PMC Article
15.

Treatment outcomes and feasibility of partial neck irradiation for patients with nasopharyngeal carcinoma with only retropharyngeal lymph node metastasis after intensity-modulated radiotherapy.

Chen M, Tang LL, Sun Y, Mao YP, Li WF, Guo R, Liu LZ, Li L, Lin AH, Ma J.

Head Neck. 2014 Apr;36(4):468-73. doi: 10.1002/hed.23314. Epub 2013 Jun 18.

PMID:
23780916
[PubMed - in process]
16.

Prognostic significance of the various classifications for parapharyngeal space involvement in nasopharyngeal carcinoma.

Huang PY, Sun ZY, Xie CM, Chen QY, Wen YF, Li J, Qiu HZ, Liu H, Zhong ZL, Mai HQ, Mo HY.

Acta Otolaryngol. 2012 Nov;132(11):1197-207. doi: 10.3109/00016489.2012.691211. Epub 2012 Jun 12.

PMID:
22690693
[PubMed - indexed for MEDLINE]
17.

Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.

Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, Leung SF, Zee B, Chan AT.

Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1440-50.

PMID:
15590175
[PubMed - indexed for MEDLINE]
18.

Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.

Han L, Lin SJ, Pan JJ, Chen CB, Zhang Y, Zhang XC, Liao XY, Chen QS.

Chin J Cancer. 2010 Feb;29(2):145-50.

PMID:
20109341
[PubMed - indexed for MEDLINE]
Free Article
19.

Does MRI-Detected Cranial Nerve Involvement Affect the Prognosis of Locally Advanced Nasopharyngeal Carcinoma Treated with Intensity Modulated Radiotherapy?

Zong J, Lin S, Chen Y, Wang B, Xiao Y, Lin J, Li R, Pan J.

PLoS One. 2014 Jun 25;9(6):e100571. doi: 10.1371/journal.pone.0100571. eCollection 2014.

PMID:
24963626
[PubMed - in process]
Free PMC Article
20.

Clinical outcome for nasopharyngeal carcinoma with predominantly WHO II histology treated with intensity-modulated radiation therapy in non-endemic region of China.

Zhao LN, Zhou B, Shi M, Wang JH, Xiao F, Xu M, Luo SQ, Xue Y, Li JP, Tan LN.

Oral Oncol. 2012 Sep;48(9):864-9. doi: 10.1016/j.oraloncology.2012.03.001. Epub 2012 Mar 24.

PMID:
22445296
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk